ofloxacin has been researched along with Pulmonary Eosinophilia in 1 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The woman was diagnosed with eosinophilic pneumonia complicated by bronchial asthma." | 5.31 | [Levofloxacin-induced eosinophilic pneumonia complicated by bronchial asthma]. ( Arakawa, M; Fujimori, K; Gejyo, F; Shimatsu, Y; Suzuki, E, 2000) |
| "The woman was diagnosed with eosinophilic pneumonia complicated by bronchial asthma." | 1.31 | [Levofloxacin-induced eosinophilic pneumonia complicated by bronchial asthma]. ( Arakawa, M; Fujimori, K; Gejyo, F; Shimatsu, Y; Suzuki, E, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimori, K | 1 |
| Shimatsu, Y | 1 |
| Suzuki, E | 1 |
| Arakawa, M | 1 |
| Gejyo, F | 1 |
1 other study available for ofloxacin and Pulmonary Eosinophilia
| Article | Year |
|---|---|
[Levofloxacin-induced eosinophilic pneumonia complicated by bronchial asthma].
Topics: Aged; Anti-Infective Agents; Asthma; Female; Humans; Levofloxacin; Ofloxacin; Pulmonary Eosinophilia | 2000 |